vs
Healthpeak Properties（DOC）与FMC CORP（FMC）财务数据对比。点击上方公司名可切换其他公司
FMC CORP的季度营收约是Healthpeak Properties的1.1倍（$759.0M vs $719.4M），Healthpeak Properties净利率更高（73.2% vs -37.0%，领先110.2%），Healthpeak Properties同比增速更快（3.1% vs -4.0%），Healthpeak Properties自由现金流更多（$357.0M vs $-628.1M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -14.5%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业，1883年创立之初以生产杀虫剂为主，后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车，目前在全球拥有7000名员工，业务布局广泛。
DOC vs FMC — 直观对比
营收规模更大
FMC
是对方的1.1倍
$719.4M
营收增速更快
DOC
高出7.1%
-4.0%
净利率更高
DOC
高出110.2%
-37.0%
自由现金流更多
DOC
多$985.1M
$-628.1M
两年增速更快
DOC
近两年复合增速
-14.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $759.0M |
| 净利润 | $114.0M | $-281.2M |
| 毛利率 | — | — |
| 营业利润率 | 17.4% | -10.6% |
| 净利率 | 73.2% | -37.0% |
| 营收同比 | 3.1% | -4.0% |
| 净利润同比 | 2406.4% | — |
| 每股收益（稀释后） | $0.16 | $-2.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCFMC
| Q1 26 | — | $759.0M | ||
| Q4 25 | $719.4M | $1.1B | ||
| Q3 25 | $705.9M | $542.2M | ||
| Q2 25 | $694.3M | $1.1B | ||
| Q1 25 | $702.9M | $791.4M | ||
| Q4 24 | $698.0M | $1.2B | ||
| Q3 24 | $700.4M | $1.1B | ||
| Q2 24 | $695.5M | $1.0B |
净利润DOCFMC
| Q1 26 | — | $-281.2M | ||
| Q4 25 | $114.0M | $-1.7B | ||
| Q3 25 | $-117.1M | $-569.3M | ||
| Q2 25 | $31.7M | $66.7M | ||
| Q1 25 | $42.8M | $-15.5M | ||
| Q4 24 | $4.5M | $-16.3M | ||
| Q3 24 | $85.9M | $65.0M | ||
| Q2 24 | $146.0M | $295.1M |
毛利率DOCFMC
| Q1 26 | — | — | ||
| Q4 25 | — | 39.8% | ||
| Q3 25 | 58.6% | 23.8% | ||
| Q2 25 | 60.2% | 38.7% | ||
| Q1 25 | 61.1% | 40.0% | ||
| Q4 24 | 60.3% | 42.9% | ||
| Q3 24 | 60.0% | 36.3% | ||
| Q2 24 | 60.6% | 38.3% |
营业利润率DOCFMC
| Q1 26 | — | -10.6% | ||
| Q4 25 | 17.4% | -130.8% | ||
| Q3 25 | 9.2% | -73.1% | ||
| Q2 25 | 5.7% | 12.0% | ||
| Q1 25 | 7.7% | 7.4% | ||
| Q4 24 | -2.2% | 19.2% | ||
| Q3 24 | 14.1% | 12.7% | ||
| Q2 24 | 22.3% | 6.0% |
净利率DOCFMC
| Q1 26 | — | -37.0% | ||
| Q4 25 | 73.2% | -158.8% | ||
| Q3 25 | -16.6% | -105.0% | ||
| Q2 25 | 4.6% | 6.3% | ||
| Q1 25 | 6.1% | -2.0% | ||
| Q4 24 | 0.7% | -1.3% | ||
| Q3 24 | 12.3% | 6.1% | ||
| Q2 24 | 21.0% | 28.4% |
每股收益（稀释后）DOCFMC
| Q1 26 | — | $-2.25 | ||
| Q4 25 | $0.16 | $-13.77 | ||
| Q3 25 | $-0.17 | $-4.52 | ||
| Q2 25 | $0.05 | $0.53 | ||
| Q1 25 | $0.06 | $-0.12 | ||
| Q4 24 | $0.02 | $-0.13 | ||
| Q3 24 | $0.12 | $0.52 | ||
| Q2 24 | $0.21 | $2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $390.9M |
| 总债务越低越好 | $9.8B | $2.8B |
| 股东权益账面价值 | $7.5B | $1.8B |
| 总资产 | $20.3B | $9.4B |
| 负债/权益比越低杠杆越低 | 1.31× | 1.50× |
8季度趋势，按日历期对齐
现金及短期投资DOCFMC
| Q1 26 | — | $390.9M | ||
| Q4 25 | $467.5M | $584.5M | ||
| Q3 25 | $91.0M | $497.7M | ||
| Q2 25 | $89.4M | $438.2M | ||
| Q1 25 | $70.6M | $315.3M | ||
| Q4 24 | $119.8M | $357.3M | ||
| Q3 24 | $180.4M | $416.7M | ||
| Q2 24 | $106.9M | $471.5M |
总债务DOCFMC
| Q1 26 | — | $2.8B | ||
| Q4 25 | $9.8B | $3.4B | ||
| Q3 25 | $9.1B | $3.4B | ||
| Q2 25 | $9.0B | $3.4B | ||
| Q1 25 | $8.9B | $3.1B | ||
| Q4 24 | $8.7B | $3.1B | ||
| Q3 24 | $8.6B | $3.1B | ||
| Q2 24 | $8.6B | $3.1B |
股东权益DOCFMC
| Q1 26 | — | $1.8B | ||
| Q4 25 | $7.5B | $2.1B | ||
| Q3 25 | $7.6B | $3.8B | ||
| Q2 25 | $7.9B | $4.4B | ||
| Q1 25 | $8.2B | $4.4B | ||
| Q4 24 | $8.4B | $4.5B | ||
| Q3 24 | $8.6B | $4.6B | ||
| Q2 24 | $8.8B | $4.6B |
总资产DOCFMC
| Q1 26 | — | $9.4B | ||
| Q4 25 | $20.3B | $9.7B | ||
| Q3 25 | $19.6B | $12.1B | ||
| Q2 25 | $19.8B | $12.3B | ||
| Q1 25 | $19.8B | $11.8B | ||
| Q4 24 | $19.9B | $11.7B | ||
| Q3 24 | $20.0B | $12.2B | ||
| Q2 24 | $20.2B | $12.1B |
负债/权益比DOCFMC
| Q1 26 | — | 1.50× | ||
| Q4 25 | 1.31× | 1.62× | ||
| Q3 25 | 1.20× | 0.89× | ||
| Q2 25 | 1.14× | 0.76× | ||
| Q1 25 | 1.08× | 0.71× | ||
| Q4 24 | 1.04× | 0.69× | ||
| Q3 24 | 1.00× | 0.68× | ||
| Q2 24 | 0.98× | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | — |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $-628.1M |
| 自由现金流率自由现金流/营收 | 49.6% | -82.8% |
| 资本支出强度资本支出/营收 | 124.4% | 2.2% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $-154.0M |
8季度趋势，按日历期对齐
经营现金流DOCFMC
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $657.1M | ||
| Q3 25 | $315.0M | $-184.2M | ||
| Q2 25 | $363.5M | $65.9M | ||
| Q1 25 | $279.4M | $-545.0M | ||
| Q4 24 | $1.1B | $427.9M | ||
| Q3 24 | $318.2M | $159.5M | ||
| Q2 24 | $316.2M | $292.2M |
自由现金流DOCFMC
| Q1 26 | — | $-628.1M | ||
| Q4 25 | $357.0M | $631.1M | ||
| Q3 25 | — | $-207.9M | ||
| Q2 25 | — | $50.9M | ||
| Q1 25 | — | $-576.6M | ||
| Q4 24 | $333.7M | $406.3M | ||
| Q3 24 | — | $143.8M | ||
| Q2 24 | — | $282.3M |
自由现金流率DOCFMC
| Q1 26 | — | -82.8% | ||
| Q4 25 | 49.6% | 58.3% | ||
| Q3 25 | — | -38.3% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | -72.9% | ||
| Q4 24 | 47.8% | 33.2% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | — | 27.2% |
资本支出强度DOCFMC
| Q1 26 | — | 2.2% | ||
| Q4 25 | 124.4% | 2.4% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | 105.6% | 1.8% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.0% |
现金转化率DOCFMC
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | 0.99× | ||
| Q1 25 | 6.52× | — | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | 2.45× | ||
| Q2 24 | 2.17× | 0.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
FMC
| EMEA | $307.0M | 40% |
| North America | $198.0M | 26% |
| Latin America | $177.0M | 23% |
| Asia (excluding 2026 India) 1 | $81.0M | 11% |
